Sickle Cell Disease Treatment Demonstration Program 2017 Congressional Report

The Sickle Cell Disease Treatment Demonstration Program (SCDTDP) was funded by Congress in 2004 to improve the care of patients with SCD. In the most recent 2014-2017 SCDTDP award, NICHQ ran the SCDTDP National Coordinating Center. This Congressional Report details the many activities, outcomes, lessons learned and recommendations stemming from this work.

Also included here is the Executive Summary of the report.